Adlai Nortye (ANL) Payables (2022 - 2025)
Adlai Nortye (ANL) reported Payables of $37.2 million for Q4 2025, up 2.04% year-over-year from $36.5 million in Q4 2024, and up 284.58% on a QoQ basis from $9.7 million in Q2 2025.
Adlai Nortye (ANL) has 4 years of Payables data on file, last reported at $37.2 million in Q4 2025.
- Quarterly Payables rose 2.04% year-over-year to $37.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $37.2 million (up 2.04% YoY) and the FY2025 annual result came in at $37.2 million, up 2.04% from the prior year.
- Payables climbed to $37.2 million in Q4 2025 per ANL's latest filing, from $9.7 million in the prior quarter.
- Across five years, Payables topped out at $44.7 million in Q4 2023 and bottomed at $9.7 million in Q2 2025.
- The 4-year median for Payables is $26.9 million (2022), against an average of $26.1 million.
- The widest annual swing landed in 2023, when Payables jumped 156.85%; it then declined 18.41% in 2024.
- Tracing ANL's Payables over 4 years: stood at $17.4 million in 2022, then jumped by 156.85% to $44.7 million in 2023, then retreated by 18.41% to $36.5 million in 2024, then climbed by 2.04% to $37.2 million in 2025.
- Per Business Quant, the three latest ANL Payables figures stand at $37.2 million (Q4 2025), $9.7 million (Q2 2025), and $36.5 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 1.03 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | 37.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.22 Mn |
| Jun 30, 2025 | 9.68 Mn |
| Dec 31, 2024 | 36.48 Mn |
| Jun 30, 2024 | 11.00 Mn |
| Dec 31, 2023 | 44.71 Mn |
| Dec 31, 2022 | 17.41 Mn |